MNEMO THERAPEUTICS
Live / Registered — Registered (as of 05 Sept 2023)
What this means for you
Registered since 05 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79330694
- Registration number
- 7152728
- Mark type
- Design + words
- Filed
- 14 Sept 2021
- Published for opposition
- 20 Jun 2023
- Registered
- 05 Sept 2023
- Attorney of record
- Jill Anderfuren
Goods and services
- Class 001 — Chemicals: Biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions
- Class 005 — Pharmaceuticals: Pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for the treatment of cancer and tumors using immunotherapy; therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; antigens, antibodies, cells for therapeutic use
- Class 010 — Medical apparatus: apparatus and instruments for carrying out tests and diagnostics for medical use, namely, medical imaging, biopsies, genetic and molecular analysis ; medical apparatus and instruments for identifying, screening, and analyzing antigens for medical use; medical apparatus for reading of analytical tests, namely molecular, blood and genetic testing
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; Custom manufacturing of antigens, antibodies, T-cells; Providing manufacturing information in the field of pharmaceuticals
- Class 042 — Scientific and technological services: Scientific research services for medical purposes, namely, medical research; Scientific research and development services for identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific information with regard to immunotherapy; Scientific research and development services, namely, providing services for the identification, analysis, authentication, purification and development of biological material from a genomic platform; Scientific research, namely, epigenetic antigen identification and screening services for therapeutic research purposes; Scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; Scientific and medical research services, namely, designing algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteristics of antigens and immunological responses
- Class 044 — Medical, beauty and agricultural services: Providing medical information with regard to immunotherapy
Owner
- MNEMO THERAPEUTICS, FR
- MNEMO THERAPEUTICS, FR
- MNEMO THERAPEUTICS, FR
Prosecution history
- 26 Dec 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 06 Dec 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 06 Dec 2023 — FINAL DISPOSITION PROCESSED
- 05 Dec 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jun 2023 — PUBLISHED FOR OPPOSITION
- 19 Jun 2023 — NOTIFICATION PROCESSED BY IB
- 31 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 31 May 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 31 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2023 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 19 Apr 2023 — REFUSAL PROCESSED BY IB
- 14 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER